GEMALTO
14.5.2018 07:02:08 CEST | Business Wire | Press release
Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, is strengthening trust in the smart energy sector with an end-to-end security solution which protects the entire ecosystem. Deployed by smart meter makers and distribution systems operators, the offer provides seamless connectivity solutions, secure digital identities and security lifecycle management for the long life of smart meters, as threats and stakeholders evolve over time. The solution protects connected energy assets and the data they exchange, allowing people and businesses to trust the expanding smart grid.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180513005007/en/
Secure smart grids improve sustainability, efficiency and reduce
threats
Today’s highly successful smart grids have become
comprehensive IoT networks with millions of connected meters that share
massive real time data about people, businesses and energy consumption.
The valuable insight they provide enables consumers to save on energy
bills and utilities and energy players to better balance supply and
demand. It is also crucial information to help integrate renewable
energy sources, helping to improve sustainability. As the marketplace
and number of connections continues to expand by an estimated 30% each
year1
, so does the cyberattack surface. The motivations for
hacking this critical infrastructure are high and diverse: energy
consumption fraud, insight into households’ activity and absence, grid
instability, pressure on governments, ID theft. Digital security is
paramount to an efficient grid´s success.
Click to watch the IoT Smart Energy video
Gemalto protects and secures the expanding smart grid sector
The
dedicated Gemalto cybersecurity
solution for electric utilities
establishes a foundation of trust at
the very core of the ecosystem by establishing end-to-end security
between energy meters, data concentrators and energy companies’ back-end
systems. Rugged and reliable IoT connectivity
modules
ensure 24/7 data availability. A strong and unique
digital identity system is implemented at the manufacturing stage to
ensure devices and applications can strongly authenticate themselves,
proving their legitimacy to access sensitive data. Leading-edge encryption
technology
safeguards against data tampering and strong security
lifecycle management enables remote security and data access updates,
without costly truck rolls.
“The smart energy ecosystem is one of the most advanced in terms of security requirements because of the potentially disastrous consequences of malicious hacking,” said Guillaume Lafaix, senior vice president Mobile Services and IoT, Gemalto. “The Gemalto cybersecurity solution for Utilities ensures the integrity and confidentiality of smart meter data while defending against hacking and emerging threats that are typical to this business.”
To learn more about the Gemalto cyber-security solution for Utilities,
please visit us at African Utility Week from May 15-17 in Cape Town. Or
check our dedicated webpages:
Gemalto
at African Utility Week
Gemalto
smart metering solutions
Gemalto
security lifecycle management for Utilities
About Gemalto
Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security , with 2017 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.
From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.
Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.
Our 15,000 employees operate out of 114 offices, 40 personalization and data centers, and 35 research and software development centers located in 47 countries.
For more information visit www.gemalto.com , or follow @gemalto on Twitter.
1 https://www.technocracy.news/index.php/2017/08/03/global-smart-grid-market-growing-at-30-per-year/
View source version on businesswire.com: https://www.businesswire.com/news/home/20180513005007/en/
Contact:
Gemalto media:
Tauri Cox, +1 512 257 3916
North America
tauri.cox@gemalto.com
or
Sophie
Dombres, +33 4 42 36 57 38
Europe Middle East & Africa
sophie.dombres@gemalto.com
or
Jaslin
Huang, +65 6317 3005
Asia Pacific
jaslin.huang@gemalto.com
or
Enriqueta
Sedano, +52 5521221422
Latin America
enriqueta.sedano@gemalto.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release
Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 10:11:00 CEST | Press release
Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize
Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 08:00:00 CEST | Press release
Employee-led recognition places Boomi among the UK's top medium-sized employers, with a flight risk of just 3% against a technology sector average of 42% Boomi achieves an average employee happiness score of 86%, rated Excellent across all six dimensions of WorkL's workplace framework Flight risk of just 3%, compared to a technology sector average of 42%, reflecting exceptional levels of employee loyalty Rated Excellent for Diversity and Inclusion and Confidence in Management Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.b
LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 07:09:00 CEST | Press release
The deal would be part of a 360° partnership with Randstad involving: Proposed acquisition of USD 500M+ (€469M) business, primarily across Aerospace & Defence, Automotive, Utilities and BFS Five-year IT services partnership to drive AI-enabled transformation for Randstad’s India Global Capability Center Strategic talent MSP to support LTM’s expanding global workforce LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through cen
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 07:00:00 CEST | Press release
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
